Breo Ellipta 200/25 TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: fluticasone furoate + vilanterol
Brand name
(ARTG)
: BREO ELLIPTA fluticasone furoate 200 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalationDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Asthma,Breo Ellipta is indicated in the regular treatment of moderate to severe asthma in patients who require a medium to high dose inhaled corticosteroid combined with a long-acting beta-2-agonist.,Vilanterol, an active ingredient in Breo Ellipta, is a long-acting beta-2-agonist (LABA). A class effect of all LABAs can be an increased risk of asthma death (see Precautions).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Inhalation, powder for
- Inhalation
- A plastic inhaler with light grey body, pale blue mouthpiece cover and a dose counter, containing two strips of blisters each containing a white powder
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 14 pack
- 30 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient fluticasone furoate + vilanterol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
